SOLACI-SBHCI 2019 Congress | International Joint Sessions

Prestigious Scientific Societies from all over the world will attend the Congress to discuss the latest advances in interventional cardiology.

Discover the International Joint Sessions

01/08 | Paulista Room | 8:30 – 10:00 | Portuguese Society of Cardiology (APIC) Symposium – Acute Coronary Syndrome

8:30 – 8:42 – PCI in NSTEMI ACS: how and when should we intervene?
8:42 – 8:54 – MINOCA – possible approaches in the cathlab
8:54 – 9:06 – Imaging methods and physiology, when should we use them in ACS
9:06 – 9:18 – Circulatory support in the cath lab
9:18 – 9:28 – Case of ACS with multivessel disease
9:28 – 10:00 – Discussion

01/08 | Paulista Room | 10:30 – 12:00pm |
Duke University Symposium – Adjunvant Clinical treatment in PCI

10:30 – 10:42 – What is the optimal antiplatelet agent?
10:42 – 10:54 – Duration of DAPT
10:54 – 11:06 – AUGUSTUS study: anticoagulation associated to antiplatelet therapy
11:06 – 11:18 – Use of statin and other drugs
11:18 – 11:28 – Clinical Case
11:28 – 12:00 – Discussion and Questions

01/08 | Ibirapuera Room | 2:00 – 3:30pm |
Cleveland Clinic Symposium

2:00 – 2:15pm – Pre-Diabetics: Should we treat them more like diabetics? 10 years outcomes
2:15 – 2:30pm – SCAD: not so rare anymore
2:30 – 2:45pm – Should we recommend TAVR for all?
2:45 – 3:00pm – TAVR: When to use cerebral embolic protection?
3:00 – 3:10pm – Clinical Case presentation
3:10 – 3:30pm – Discussion

01/08 | Augusta Room | 12:15 –2:00pm | PICS-SOLACI-SBHCI Symposium – Valve Implant in Congenital Cardiopathies

12:15 – 12:30pm – RVOT preparation for the Sapiens Valve: Large diameter stents vs reducing devices
12:30 – 12:45pm- Reinterventions in the Melody valve: indications and outcomes
12:45- 1:00pm- Venus P Valve Implant: unfavorable anatomies, what should be done?
1:00 – 1:15pm –Pulmonary Valve Hybrid Implant. Indications and techniques
1:15 – 1:30pm -Endocarditis in percutaneous valves: what are the evidences?
1:30 – 1:45pm – Discussion
1:45 – 2:00pm -Mini Conference: Paravalvular Leak with the Occlutech PLD device

02/08 | Ibirapuera Room | 8:30 – 10:00 | TCT Symposium Controversies

8:30 – 8:42 – PCI in Stable Ischemic Heart Disease
8:42 – 9:00 – Clinical Case
9:00 – 9:12 – TAVR in Low Risk Patients
9:12 – 9:30 – Clinical Case
9:30 – 9:42 – Mitral Repair X Replacement
9:42 – 10:00 – Clinical Case

02/08 | Ibirapuera Room | 2:00 – 4:00pm | EuroPCR Symposium: Current Indications of Drug Coated Balloons (DCB)

2:00 – 2:15pm – Coronary applications of DCB
2:15 – 2:30pm – Clinical case – ISR
2:30 – 2:45pm – Concept and clinical results of a novel Sirolimus coated balloon: Magic Touch
2:45 – 3:00pm – Clinical case – small vessel
3:00 – 3:15pm – Peripheral applications of DCB
3:15 – 3:30pm – Clinical case
3:30 – 4:00pm – Discussion

More articles by this author

Download your SOLACI-SBHCI 2019 Congress Certificate

If you took part in the SOLACI-SBHCI 2019 Congress you can get your certificate by sending an email to gerencia@sbhci.org and/or marianna@atualeventos.com. We expect you...

Celebrating 10 Years of ProEducar Fellow Course with Record Attendance

This year SOLACI celebrated the 10th issue of ProEducar Fellow Course during SOLACI-SBHCI 2019 in Sao Paulo. The course was a roaring success: not...

Dr. José Mangione Inaugurated as New SOLACI President

Dr. José Mangione, renowned Latin American interventional cardiologist of ample trajectory, is now in charge of the Latin American Interventional Cardiology’s destiny for the...

Last Congress Day Full of SOLACI Activities

The last day of the SOLACI-SBHCI 2019 Congress was full of sessions where different SOLACI areas were widely represented. The first morning session was...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...